Lupus Nephritis Clinical Trials in Philadelphia, Pennsylvania

4 studies are recruiting for lupus nephritis in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

    This phase II, randomized, double-blind, placebo-controlled study is designed to evaluate the safety, efficacy and pharmacokinetics (PK) of obinutuzumab in adolescent participants (AP) aged 12 to less than 18 with biopsy-confirmed proliferative lupus nephritis (LN). It will also evaluate open label…

    Stage
    Phase 2
    Ages
    5 to 17
    Site
    Chldren?s Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    44 in total
    Run by
    Hoffmann-La Roche

    See if you can join NCT05039619 on ClinicalTrials.gov

  2. RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    Stage
    Phase 1
    Ages
    12 to 65
    Site
    Children's Hospital of Philadelphia - Accepting Young Adult and Adolescent Patients, Philadelphia, Pennsylvania
    Locations
    23 in total
    Run by
    Cabaletta Bio

    See if you can join NCT06121297 on ClinicalTrials.gov

  3. VIBRANT: VIB4920 for Active Lupus Nephritis

    This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Temple University, Lewis Katz School of Medicine, Department of Medicine: Nephrology, Philadelphia, Pennsylvania
    Locations
    17 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT05201469 on ClinicalTrials.gov

  4. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

    This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate-to-severe active systemic lupus erythematosus (SLE) with or without nephritis, antine…

    Stage
    Phase 1
    Ages
    12 to 70
    Site
    Jefferson Einstein Hospital Philadelphia, Philadelphia, Pennsylvania
    Locations
    21 in total
    Run by
    Fate Therapeutics

    See if you can join NCT06308978 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.